Friday, July 10, 2026

pharma · Moderate to severe pain associated with Osteoarthritis of the knee · Not applicable for phase I study

Grünenthal

News and analysis for Grünenthal on NovaPharmaNews — regulatory, clinical, and market coverage.

Aachen, DE HQ
4,668 Employees
EMA registrant Type
Company details
Status
Public
HQ
Aachen, DE
Employees
4,668
Programs
3
Drugs
5
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Grünenthal — regulatory, clinical, and market coverage.

News and analysis for Grünenthal on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Grünenthal yet.

Back to company overview →